The Food and Drug Administration’s approval of the abortion drug RU-486 sparked a new round of debate between pro-life and pro-choice activists, but it also brought forth a new discussion about the drug’s medical benefits and drawbacks, who will be allowed to administer it, and how states will regulate its use. A panel talks about the new concerns raised by the introduction of RU-486 in the U.S.

Guests

  • Richard Pierce professor of administrative law at George Washington University
  • Dr. Mitchell Creinin physician
  • Maxine Klane Planned Parenthood of Metropolitan Washington

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Friday News Roundup – International

Friday, Dec 02 2016President-elect Trump chooses a retired Marine general to head the Pentagon. Syrian rebels agree to form a new alliance as the regime bombards Aleppo. And thousands of Cubans turn out to watch Fidel Castro's funeral procession. A panel of journalists joins Diane for analysis of the week's top international news stories.

Friday News Roundup – Domestic

Friday, Dec 02 2016President-elect Donald Trump starts a victory tour with a stop in Cincinnati. Nancy Pelosi is re-elected House minority leader. And North Carolina prosecutors say the police officer who killed Keith Lamont Scott will not face charges.